PATENT CLAIM ANALYSIS

Application Number: 15978075
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "094610"]

Abstract:
In certain embodiments, the present disclosure provides compositions and methods for treating Pompe disease.

Claim (Index 13):
The chimeric polypeptide of  claim 1 , wherein the antibody is:\n a) a monoclonal antibody 3E10, or a variant thereof that retains cell penetrating activity, or a variant thereof that binds the same epitope as 3E10, or an antibody that has substantially the same cell penetrating activity as 3E10 and binds the same epitope as 3E10; or b) a monoclonal antibody 3E10, or a variant thereof that retains the cell penetrating activity of 3E10.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14769270', '15318256', '14485524', '14100517', '12589118']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7610058724417935
- 35 USC 102 Novelty (BERT): 0.64872675956114
- Combined Prediction Score: 0.7497779611537282
- Mean Citation Score: 469.374158
- Max Citation Score: 634.4995
- Similarity Product: 572.700641895771

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test